OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)

✍ Scribed by Fleseriu, M.; Gadelha, M.; Bronstein, M.D.; Brue, T.; Coculescu, M.; Guitelman, M.; Pronin, V.; Raverot, G.; Shimon, I.; Fleck, J.; Aout, M.; Pedroncelli, A.M.; Colao, A.

• Book ID: 126759727
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 462 KB
• Volume: 24
• Category: Article
• ISSN: 1096-6374
• DOI: 10.1016/S1096-6374(14)50053-6